Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 11, 1997, Pages 863-873

  Tulinius, Hrafn ^a,b   Sigfússon, Nikulás ^c   Sigvaldason, Helgi ^a   Bjarnadóttir, Kristín ^a   Tryggvadóttir, Laufey ^a  

^a ICELANDIC CANCER REGISTRY   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; FEMALE; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEOPLASM; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; ICELAND; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 0030727513     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thrainsdottir, I. S., Hardarson, T., Thorgeirsson, G., Sigvaldason, H., and Sigfússon, N. The epidemiology of right bundle branch block and its association with cardiovascular morbidity: The Reykjavík Study. Eur. Heart J., 14: 1590-1596, 1993.
2. Björnsson, O. J., Davidsson, D., Ólafsson, Ó., Sigfússon, N., and Thorsteinsson, T. Survey of serum lipid-levels in Icelandic men aged 34-61 years. An epidemiological and statistical evaluation. Acta Med. Scand., 15 (Suppl. 616): 1-150, 1977.
3. Bjarnason, O., and Tulinius, H. Cancer registration in Iceland, 1955-1974. Acta Pathol. Microbiol. Scand. Sect. A, 91 (Suppl. 281): 1-120, 1983.
4. Tulinius, H., Sigfússon, N., Sigvaldason, H., and Day, N. E. Can anthropometric and biochemical measurements illustrate the diet-cancer connection? Näringsforskning, 29: 17-22, 1985.
5. Tulinius, H., Sigfússon, N., Sigvaldason, H., and Day, N. E. Relative weight and human cancer risk. In: J. V. Joosens, M. J. Hill, and J. Gebors (eds.). Diet and Human Carcinogenesis, pp. 173-179. Elsevier Science Publishers, 1985.
6. McDuffie, H. H., Klaassen, D. J., and Dosman, J. A. Female-male differences in patients with primary lung cancer. Cancer (Phila.), 59: 1825-1830, 1987.
7. Cohn, B. A., Wingard, D. L., Cirillo, P. M., Cohen, R. D., and Kaplan, G. A. Is cigarette smoking a stronger risk factor for lung cancer mortality for women than for men? Evidence from a cohort study with follow-up into the 1980s. Abstr. Am. J. Epidemiol., 126: 767, 1987.
8. Brownson, R. C., Chang, J. C., and Davies, J. R. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology, 3: 61-64, 1992.
9. Osann, K. E., Anton-Culver, H., Kurosaki, T., and Taylor, T. Sex differences in lung-cancer risk associated with cigarette smoking. Int. J. Cancer, 54: 44-48, 1993.
10. Risch, H. A., Howe, G. R., Jain, M., Burch, J. D., Holowaty, E. J., and Miller, A. B. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J. Epidemiol., 138: 281-293, 1993.
11. Begg, C. B., Zhang, Z., Sun, M, Herr, H. W., and Schantz, S. P. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the surveillance, epidemiology, and end results (SEER) program. Am J. Epidemiol., 142: 653-665, 1995.
12. Zang, E. A., and Wynder, E. L. Differences in lung cancer risk between men and women. Examination of the evidence. J. Natl. Cancer Inst., 88: 183-192, 1996.
13. Cohn, B. A., Wingard, D. L., Cirillo, P. M., Cohen, R. D., Reynolds, P., and Kaplan, G. A. Re: "Differences in lung cancer risk between men and women: examination of the evidence" (Letter; Comment). J. Natl. Cancer Inst. (Bethesda), 88: 1867-1868, 1996.
14. Weiss, N. Re: "Differences in lung cancer risk between men and women: examination of the evidence" (Letter; Comment). J. Natl. Cancer Inst. (Bethesda), 88: 764, 1996.
15. Lubin, J. H., and Blot, W. J. Assessment of lung cancer risk factors by histologic type. J. Natl. Cancer Inst. (Bethesda), 75: 383-389, 1984.
16. Adami, H-O., Persson, I., Hoover, R., Schairer, C., and Bergkvist, L. Risk of cancer in women receiving hormone replacement therapy. Int. J. Cancer, 44: 833-839, 1989.
17. Taioli, E., and Wynder, E. Re: "Endocrine factors and adenocarcinoma of the lung in women" (Letter). J. Natl. Cancer Inst. (Bethesda), 86: 869-870, 1994.
18. Rubin, G. L., Peterson, H. B., Lee, N. C., Maes E. F., Wing, P. A., and Becker, S. Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. Am. J. Obstet. Gynecol., 162: 148-154, 1990.
19. Brinton, L. A., Hoover, R. N., and the Endometrial Cancer Collaborative Group. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet. Gynecol., 81: 265-271, 1993.
20. Swanson, C. A., Potischman, N., Barrett, R. J., Berman, M. L., Mortel, R., Twiggs, L. B., Wilbanks, G. D., Hoover, R. N., and Brinton, L. A. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol. Biomark. Prev., 3: 575-581, 1994.
21. MacMahon, B., Trichopoulos, D., Cole, P., and Brown, J. Cigarette smoking and urinary estrogens. N. Engl. J. Med., 507: 1062-1065, 1982.
22. Michnovicz, J. J., Herschkopf, R. J., Naganuma, H., Bradlow, H. L., and Fishman, J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N. Engl. J. Med., 315: 1305-1309, 1986.